PB-027Purity on request

Fig. · White to off-white lyophilized powder; typically exists as solid at room temperature

Oncology Research Peptides

Tertomotide (GV1001) Hydrochloride

C₈₅H₁₄₇ClN₂₆O₂₁ · 1904.69 g/mol

Tertomotide (GV1001) is a synthetic 16-amino-acid peptide derived from the catalytic subunit of human telomerase (hTERT), studied as a research-grade peptide-vaccine candidate. It is investigated in immuno-oncology research for telomerase-directed immune-response induction, and separately in neuroscience research for cell-penetrating and neuroprotective properties relevant to amyloid-beta and tau pathology studies.

Purity

On request

Quantity

Milligram, gram, or bulk quantities

Documentation

COA, HPLC, MS / LC-MS, SDS

Packaging

Bulk, non-branded, or private label

Request a Quote Request Documentation

Research Use Only · Buyer verification required

Specifications

Technical profile.

Catalog Number

PB-027

CAS Number

922174-60-5

Sequence

H-Glu-Ala-Arg-Pro-Ala-Leu-Leu-Thr-Ser-Arg-Leu-Arg-Phe-Ile-Pro-Lys-OH

Molecular Formula

C₈₅H₁₄₇ClN₂₆O₂₁

Molecular Weight

1904.69 g/mol

Purity (HPLC)

Available specifications confirmed with quotation

Appearance

White to off-white lyophilized powder; typically exists as solid at room temperature

Vial Size

Confirmed with quotation

Storage

−20 °C, sealed, desiccated

Reconstitution

Bacteriostatic water

Classification

Research Use Only

Documentation & Quality

What documentation may be available for Tertomotide (GV1001) Hydrochloride.

Tertomotide (GV1001) Hydrochloride·PB-027

Certificate of Analysis (COA)

Manufacturing partner or independent summary of identity, purity, and other release testing for a batch.